Korro Bio, Inc.
Korro Bio, Inc. (KRRO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KRRO · as of Jun 8, 2026
Key Statistics
Explore Korro Bio, Inc. Data
krro stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 83.3%
The KRRO analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $19.57, representing +82.56% upside from the current price of $10.72.
Competitors & Peers
krro competitorsKRRO
ALT
AMRN
ANNX
ANRO
AURAStock Performance
Full HistoryAbout Korro Bio, Inc.
Korro Bio, Inc. a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is…
what is korro bio, inc. · krro stock overview · korro bio, inc. company profile · who is korro bio, inc. ceo · krro NASDAQ · korro bio, inc. headquarters · korro bio, inc. business segments
About Stock Overview & Key Data
Korro Bio, Inc. (KRRO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 3, 2019. As of the latest trading session, KRRO stock price is $10.72, with a market capitalization of $105.6M. The stock has returned -28.57% over the past 12 months and +32.43% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Korro Bio, Inc. stock is Buy, with an average 12-month price target of $19.57. In fiscal year 2025, Korro Bio, Inc. reported revenue of $6.4M and net income of -$117.3M. For detailed data — including Korro Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Korro Bio, Inc. (KRRO) stock price is $10.72. The stock is traded on NASDAQ under the ticker symbol KRRO. The 52-week range is $5.20 – $55.89.